Key Strategies for Biomarker Detection in NSCLC

Download these slides to review expert insights from a molecular pathologist on best practices for biomarker testing in the treatment of patients with advanced NSCLC.
Lauren L. Ritterhouse, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.32 MB
Released: October 13, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Merck Sharp & Dohme Corp.

Related Content

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for gastroesophageal cancers

Manish A. Shah, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for pancreatic and biliary tract cancers

Rachna Shroff, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for colorectal cancer (CRC)

John L. Marshall, MD Released: January 21, 2022

Downloadable powerpoint slideset with key takeways on the use of immune checkpoint inhibitors for resectable early-stage NSCLC, from Clinical Care Options (CCO)

Justin F. Gainor, MD
Program Director
Released: January 18, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings